1  813 157 CHANGES IN POLY(ADP-RIBOSYL)ATION PATTERNS IN WORKERS EXPOSED TO BTX. OCCUPATIONAL EXPOSURE TO (BENZENE, TOLUENE AND XYLENE, BTX IS COMMON IN THE CHINESE WORKPLACE. CHRONIC OCCUPATIONAL EXPOSURE TO BENZENE IS ASSOCIATED WITH AN INCREASED RISK OF HEMATOLOGICAL MALIGNANCIES SUCH AS ACUTE MYELOID LEUKEMIA (AML), BUT THE UNDERLYING MECHANISMS ARE STILL UNCLEAR. THIS STUDY INVESTIGATES CHANGES IN POLY(ADP-RIBOSYL)ATION AND DNA METHYLATION IN SUBJECTS OCCUPATIONALLY EXPOSED TO A BTX. BLOOD DNA SAMPLES AND EXPOSURE DATA WERE OBTAINED FROM SUBJECTS WITH DIFFERENT LEVELS OF EXPOSURE, INCLUDING 132 DECORATORS, 129 PAINTERS, AND 130 UNEXPOSED REFERENTS IN A CONTAINER-MANUFACTURING FACTORY IN SHENZHEN, CHINA. OCCUPATIONAL EXPOSURE ASSESSMENT INCLUDED PERSONAL MONITORING OF AIRBORNE BENZENE, TOLUENE AND XYLENE. HEMATOLOGICAL PARAMETERS WERE MEASURED AND THE CYTOKINESIS-BLOCK MICRONUCLEUS (CBMN) ASSAY WAS USED TO DETECT DNA DAMAGE IN PERIPHERAL LYMPHOCYTES. QUANTITATIVE REAL-TIME PCR WAS USED TO DETECT THE MRNA EXPRESSION OF POLY(ADP-RIBOSE) POLYMERASE 1 (PARP1) AND POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG), DNA METHYLTRANSFERASES (DNMTS) INCLUDING DNMT1, DNMT3A AND DNMT3B, METHYL-CPG-BINDING DOMAIN PROTEIN 2(MBD2). PARP1 ASSAY WAS USED TO MEASURE PARP ACTIVITY. AIRBORNE LEVELS OF BENZENE, TOLUENE AND XYLENE IN THE TWO EXPOSED GROUPS WERE SIGNIFICANTLY HIGHER THAN THOSE OF CONTROLS (P<0.001). THE TWO EXPOSED GROUPS (DECORATORS, PAINTERS) SHOWED DECREASED PARP1, DNMTS AND MBD2 EXPRESSION RELATIVE TO CONTROLS (P<0.05), AND PARP ACTIVITY WAS ALSO DECREASED (P<0.05). DECREASED PARP1, DNMT1, DNMT3A, DNMT3B AND MBD2 MRNA EXPRESSION WAS CORRELATED WITH INCREASED AIRBORNE BTX (PEARSON'S R: -0.587, -0.314, -0.636, -0.567 AND -0.592 RESPECTIVELY, P<0.001). NO SIGNIFICANT DIFFERENCES IN HEMATOLOGICAL PARAMETERS AND CBMN WERE FOUND AMONG THE THREE GROUPS. TOGETHER, THESE RESULTS SUGGEST THAT DECREASED DNMTS, MBD2 AND PARP1 MIGHT BE INVOLVED IN THE GLOBAL HYPOMETHYLATION ASSOCIATED WITH BTX EXPOSURE, AND THE IMBALANCE OF PARP/PARG MIGHT PARTICIPATE IN THE DOWN-REGULATION OF DNMTS. THIS IS THE FIRST HUMAN STUDY TO LINK ALTERED POLY(ADP-RIBOSYL)ATION PATTERNS, WHICH REPRODUCE THE ABERRANT EPIGENETIC PATTERNS FOUND IN BENZENE-TREATED CELLS, TO CHRONIC OCCUPATIONAL EXPOSURE TO BTX.	2014	

2 3441  48 HYPERMETHYLATION IN GENE PROMOTERS ARE INDUCED BY CHRONIC EXPOSURE TO BENZENE, TOLUENE, ETHYLBENZENE AND XYLENES. BACKGROUND AND OBJECTIVE: GAS STATION ATTENDANTS ARE OCCUPATIONALLY EXPOSED TO BENZENE, TOLUENE, ETHYLBENZENE AND XYLENE (BTEX) COMPOUNDS AND THUS MORE SUSCEPTIBLE TO THE BIOLOGICAL EFFECTS OF THIS MIXTURE PRESENT IN GASOLINE, ESPECIALLY DUE TO THE CARCINOGENICITY OF BENZENE. FURTHERMORE, THE HARMFUL EFFECTS OF BTEX EXPOSURE MAY BE POTENTIATED BY GENETIC AND EPIGENETIC INACTIVATION OF CRITICAL GENES. THE OBJECTIVE WAS TO EVALUATE SUCH GENE-BTEX INTERACTIONS ACCESSING THE PROMOTER METHYLATION STATUS OF P14ARF, P16INK4A AND GSTP1 IN PERIPHERAL BLOOD LEUKOCYTE SAMPLES. MATERIALS AND METHODS: THE 59 EXPOSED AND 68 UNEXPOSED PARTICIPANTS FROM RIO DE JANEIRO, BRAZIL, WERE INCLUDED. THE PROMOTER METHYLATION STATUS WAS ACCESSED BY METHYLATION-SPECIFIC PCR (MSP) AND GSTP1 ILE105VAL POLYMORPHISM WAS INVESTIGATED BY PCR-RESTRICTION FRAGMENT LENGTH POLYMORPHISM (PCR-RFLP) TECHNIQUE. RESULTS: BOTH P14ARF AND P16INK4A WERE SIGNIFICANTLY HYPERMETHYLATED IN EXPOSED SUBJECTS COMPARED TO UNEXPOSED (P = 0.004 AND P<0.001, RESPECTIVELY). ADDITIONALLY, P16INK4A HYPERMETHYLATION IN THE EXPOSED GROUP WAS CORRELATED WITH CHROMOSOMAL ABNORMALITIES (CAS) (P = 0.018), THUS HIGHLIGHTING THE INFLUENCE OF THE GENE-ENVIRONMENT INTERACTIONS ON GENOME INSTABILITY. NOTEWORTHY, P16INK4A METHYLATION WAS SIGNIFICANTLY ASSOCIATED WITH MISCARRIAGE AMONG FEMALE ATTENDANTS (P = 0.047), IN WHICH THOSE WHO REPORTED MISCARRIAGE EXHIBITED HYPERMETHYLATION IN AT LEAST 2 OF THE 3 GENES ANALYZED. THE GSTP1 HETEROZYGOTE GENOTYPE, WHICH COULD AFFECT THE METABOLISM OF BENZENE DETOXIFICATION, WAS FOUND IN BOTH GROUPS BUT WAS MORE FREQUENT IN THOSE OCCUPATIONALLY EXPOSED. NO SIGNIFICANT ASSOCIATION WAS OBSERVED BETWEEN GSTP1 GENOTYPES AND METHYLATION STATUS. CONCLUSION: TOGETHER, THESE FINDINGS INDICATE THAT GAS STATION ATTENDANTS WITH THE AFOREMENTIONED EPIGENETIC AND GENETIC PROFILES MAY BE AT GREATER RISK OF OCCUPATIONAL BTEX EXPOSURE-INDUCED GENOME INSTABILITY, WHICH COULD REQUIRE CONCERTED EFFORTS TO ESTABLISH MORE PREVENTIVE ACTIONS AND CONSTANT BIOMONITORING IN GAS STATION ATTENDANTS.	2020	
                                                                                                   
3 1264  45 CYP2E1 EPIGENETIC REGULATION IN CHRONIC, LOW-LEVEL TOLUENE EXPOSURE: RELATIONSHIP WITH OXIDATIVE STRESS AND SMOKING HABIT. BACKGROUND: CYP2E1 IS A VERSATILE PHASE I DRUG-METABOLIZING ENZYME RESPONSIBLE FOR THE BIOTRANSFORMATION OF MOST VOLATILE ORGANIC COMPOUNDS, INCLUDING TOLUENE. HUMAN TOLUENE EXPOSURE INCREASES CYP2E1 MRNA AND MODIFIES ITS ACTIVITY IN LEUCOCYTES; HOWEVER, EPIGENETIC IMPLICATIONS OF THIS INTERACTION HAVE NOT BEEN INVESTIGATED. GOAL: TO DETERMINE PROMOTER METHYLATION OF CYP2E1 AND OTHER GENES KNOWN TO BE AFFECTED BY TOLUENE EXPOSURE. METHODS: WE OBTAINED VENOUS BLOOD FROM 24 TANNERY WORKERS EXPOSED TO TOLUENE (MEAN LEVELS: 10.86+/-7MG/M(3)) AND 24 ADMINISTRATIVE WORKERS (REFERENCE GROUP, MEAN LEVELS 0.21+/-0.02MG/M(3)) ALL OF THEM FROM THE CITY OF LEON, GUANAJUATO, MEXICO. AFTER DNA EXTRACTION AND BISULFITE TREATMENT, WE PERFORMED PCR-PYROSEQUENCING IN ORDER TO MEASURE METHYLATION LEVELS AT PROMOTER REGION OF 13 GENES. RESULTS: IN EXPOSED GROUP WE FOUND SIGNIFICANT CORRELATIONS BETWEEN TOLUENE AIRBORNE LEVELS AND CYP2E1 PROMOTER METHYLATION (R=-.36, P<0.05), AS WELL AS FOR IL6 PROMOTER METHYLATION LEVELS (R=.44, P<0.05). MOREOVER, CYP2E1 PROMOTER METHYLATION LEVELS WHERE HIGHER IN TOLUENE-EXPOSED SMOKERS COMPARED TO NONSMOKERS (P=0.009). WE ALSO OBSERVED SIGNIFICANT CORRELATIONS FOR CYP2E1 PROMOTER METHYLATION WITH GSTP1 AND SOD1 PROMOTER METHYLATION LEVELS (R=-.37, P<0.05 AND R=-.34, P<0.05 RESPECTIVELY). CONCLUSION: THESE RESULTS HIGHLIGHT THE IMPORTANCE OF CONSIDERING CYP2E1 EPIGENETIC MODIFICATIONS, AS WELL AS ITS INTERACTIONS WITH OTHER GENES, AS KEY FACTORS FOR UNRAVELING THE SUB CELLULAR MECHANISMS OF TOXICITY EXERTED BY OXIDATIVE STRESS, WHICH CAN INITIATE DISEASE PROCESS IN CHRONIC, LOW-LEVEL TOLUENE EXPOSURE. PEOPLE CO-EXPOSED TO TOLUENE AND TOBACCO SMOKE ARE IN HIGHER RISK DUE TO A POSSIBLE CYP2E1 REPRESSION.	2015	
                                                                                                                                                                                                                                                                                                                                                                                                                                   
4 2714  39 EXERCISE-CONDITIONED PLASMA ATTENUATES NUCLEAR CONCENTRATIONS OF DNA METHYLTRANSFERASE 3B IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS. DNA METHYLATION IS MODIFIABLE BY ACUTE AND CHRONIC EXERCISE. DNA METHYLTRANSFERASES (DNMT) CATALYZE THIS PROCESS; HOWEVER, THERE IS A LACK OF LITERATURE CONCERNING THE SPECIFIC MECHANISMS BY WHICH EXERCISE-INDUCED MODIFICATIONS OCCUR. INTERLEUKIN 6 (IL-6) STIMULATION OF VARIOUS CELL LINES HAS BEEN SHOWN TO AUGMENT DNMT EXPRESSION AND NUCLEAR TRANSLOCATION, WHICH SUGGESTS A POSSIBLE PATHWAY BY WHICH EXERCISE IS ABLE TO ELICIT CHANGES IN EPIGENETIC ENZYMES. THE PRESENT STUDY SOUGHT TO ELUCIDATE THE RESPONSE OF THE DE NOVO METHYLTRANSFERASES DNMT3A AND DNMT3B TO CIRCULATORY FACTORS FOUND IN PLASMA ISOLATED FROM WHOLE BLOOD BEFORE AND AFTER 120-MIN OF TREADMILL RUNNING AT AN INTENSITY OF 60% OF INDIVIDUAL VELOCITY AT V O2MAX (VV O2MAX) INTERSPERSED WITH 30-SEC SPRINTS AT 90% OF VV O2MAX EVERY 10-MIN. PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) ISOLATED FROM A RESTING PARTICIPANT WERE INCUBATED WITH PLASMA ISOLATED FROM EXERCISING PARTICIPANTS (N = 10) OR RECOMBINANT IL-6 (RIL-6), FOLLOWED BY NUCLEAR PROTEIN EXTRACTION AND QUANTIFICATION OF DNMT3A AND DNMT3B CONCENTRATIONS. NUCLEAR CONCENTRATIONS OF DNMT3B SIGNIFICANTLY DECREASED FOLLOWING THE EXPERIMENTAL PROTOCOL (P = 0.03), WITH NO CHANGE OBSERVED IN DNMT3A (P = 0.514).VARIOUS CONCENTRATIONS OF RIL-6 CAUSED AN ELEVATION IN BOTH DNMT3A AND DNMT3B NUCLEAR CONCENTRATION COMPARED WITH THE BLANK CONTROL. THE CONFLICTING RESULTS BETWEEN EXERCISING AND RIL-6 CONDITIONS SUGGESTS THAT IL-6 DOES REGULATE DNMT NUCLEAR TRANSPORT, HOWEVER, OTHER PLASMA MEDIATORS MAY ALSO EXERT SIGNIFICANT INFLUENCE ON THE NUCLEAR CONCENTRATIONS OF THESE ENZYMES.	2015	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
5 1846  30 EFFECTS OF TWO TYPES OF ENERGY RESTRICTION ON METHYLATION LEVELS OF ADIPONECTIN RECEPTOR 1 AND LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT IN A MOUSE MAMMARY TUMOUR VIRUS-TRANSFORMING GROWTH FACTOR-ALPHA BREAST CANCER MOUSE MODEL. THE ROLE OF ADIPONECTIN AND LEPTIN SIGNALLING PATHWAYS HAS BEEN SUGGESTED TO PLAY IMPORTANT ROLES IN THE PROTECTIVE EFFECTS OF ENERGY RESTRICTION (ER) ON MAMMARY TUMOUR (MT) DEVELOPMENT. TO STUDY THE EFFECTS OF ER ON THE METHYLATION LEVELS IN ADIPONECTIN RECEPTOR 1 (ADIPOR1) AND LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT (LEPROT) GENES USING THE PYROSEQUENCING METHOD IN MAMMARY FAT PAD TISSUE, MOUSE MAMMARY TUMOUR VIRUS-TRANSFORMING GROWTH FACTOR-ALPHA (MMTV-TGF-ALPHA) FEMALE MICE WERE RANDOMLY ASSIGNED TO AD LIBITUM (AL), CHRONIC ER (CER, 15 % ER) OR INTERMITTENT ER (3 WEEKS AL AND 1 WEEK 60 % ER IN CYCLIC PERIODS) GROUPS AT 10 WEEKS OF AGE UNTIL 82 WEEKS OF AGE. THE METHYLATION LEVELS OF ADIPOR1 IN THE CER GROUP WERE HIGHER THAN THOSE IN THE AL GROUP AT WEEK 49/50 (P < 0.05), WHILE THE LEVELS OF METHYLATION FOR ADIPOR1 AND LEPROT GENES WERE SIMILAR AMONG THE OTHER GROUPS. ALSO, THE METHYLATION LEVELS AT CPG2 AND CPG3 REGIONS OF THE PROMOTER REGION OF THE ADIPOR1 GENE IN THE CER GROUP WERE THREE TIMES HIGHER (P < 0.05), WHILE CPG1 ISLAND OF LEPROT METHYLATION WAS SIGNIFICANTLY LOWER COMPARED WITH THE OTHER GROUPS (P < 0.05). ADIPONECTIN AND LEPTIN GENE EXPRESSION LEVELS WERE CONSISTENT WITH THE METHYLATION LEVELS. WE ALSO OBSERVED A CHANGE WITH AGEING IN METHYLATION LEVELS OF THESE GENES. THESE RESULTS INDICATE THAT DIFFERENT TYPES OF ER MODIFY METHYLATION LEVELS OF ADIPOR1 AND LEPROT IN DIFFERENT WAYS AND CER HAD A MORE SIGNIFICANT EFFECT ON METHYLATION LEVELS OF BOTH GENES. EPIGENETIC REGULATION OF THESE GENES MAY PLAY IMPORTANT ROLES IN THE PREVENTIVE EFFECTS OF ER AGAINST MT DEVELOPMENT AND AGEING PROCESSES.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                          
6 5273  39 PROMOTER METHYLATION AND BDNF AND DAT1 GENE EXPRESSION PROFILES IN PATIENTS WITH DRUG ADDICTION. BACKGROUND: DRUG ADDICTION IS A BRAIN DISORDER THAT HAS NEGATIVE CONSEQUENCES FOR INDIVIDUALS AND SOCIETY. ADDICTIONS ARE CHRONIC RELAPSING DISEASES OF THE BRAIN THAT ARE CAUSED BY DIRECT DRUG-INDUCED EFFECTS AND PERSEVERING NEUROADAPTATIONS AT THE EPIGENETIC, NEUROPEPTIDE AND NEUROTRANSMITTER LEVELS. BECAUSE THE DOPAMINERGIC SYSTEM HAS A SIGNIFICANT ROLE IN DRUG ABUSE, THE PURPOSE OF THIS STUDY WAS TO ANALYZE THE METHYLATION AND EXPRESSION PROFILE OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) AND DOPAMINE TRANSPORTER (DAT1) GENES IN INDIVIDUALS WITH DRUG ADDICTION. MATERIALS AND METHODS: BDNF AND DAT1 PROMOTER METHYLATION WERE INVESTIGATED WITH A METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION (PCR) TECHNIQUE IN BLOOD SAMPLES FROM 75 INDIVIDUALS WITH DRUG ADDICTION AND 65 HEALTHY CONTROLS. THE EXPRESSION LEVELS OF BDNF AND DAT1 WERE ASSESSED IN 12 MRNA SAMPLES FROM THE BLOOD OF PATIENTS AND COMPARED TO THE SAMPLES OF HEALTHY CONTROLS (N = 12) WITH REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION PCR. RESULTS: NO SIGNIFICANT DIFFERENCES WERE FOUND IN THE METHYLATION OF BDNF AND DAT1 BETWEEN PATIENTS AND CONTROLS, BUT THE RELATIVE LEVELS OF EXPRESSION OF BDNF AND DAT1 MRNA DIFFERED SIGNIFICANTLY IN THE PATIENTS COMPARED TO CONTROLS (P < 0.0001). CONCLUSION: THESE RESULTS SHOWED THAT THE METHYLATION STATUS OF THE BDNF AND DAT1 GENES HAD NO SIGNIFICANT FUNCTION IN THE PROCESSES OF DRUG ADDICTION.	2015	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
7 1297  52 DECREASED MRNA EXPRESSION LEVELS OF DNA METHYLTRANSFERASES TYPE 1 AND 3A IN SYSTEMIC LUPUS ERYTHEMATOSUS. OBJECTIVES: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A CHRONIC RELAPSING AUTOIMMUNE DISEASE CHARACTERIZED BY THE PRESENCE OF AUTOANTIBODIES DIRECTED AGAINST NUCLEAR ANTIGENS AND BY CHRONIC INFLAMMATION. ALTHOUGH THE ETIOLOGY OF SLE REMAINS UNCLEAR, THE INFLUENCE OF ENVIRONMENT FACTORS, WHICH IS LARGELY REFLECTED BY THE EPIGENETIC MECHANISMS, WITH DNA METHYLATION CHANGES IN PARTICULAR, IS GENERALLY CONSIDERED AS MAIN PLAYERS IN THE PATHOGENESIS OF SLE. WE STUDIED DNA METHYLTRANSFERASES' (DNMTS) TYPE 1, 3A AND 3B TRANSCRIPT LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS DIAGNOSED WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND FROM THE HEALTHY CONTROL SUBJECTS. FURTHERMORE, THE ASSOCIATION OF DNMT1, DNMT3A, AND DNMT3B MRNA LEVELS WITH GENDER, AGE, AND MAJOR CLINICAL MANIFESTATIONS WAS ANALYZED. METHODS: PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) WERE ISOLATED FROM 32 SLE PATIENTS AND 40 HEALTHY CONTROLS. REVERSE TRANSCRIPTION AND REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION (RT-QPCR) ANALYSES WERE USED TO DETERMINE DNMT1, DNMT3A, AND DNMT3B MRNA EXPRESSION LEVELS. RESULTS: SIGNIFICANTLY LOWER DNMT1 (P = 0.015543) AND DNMT3A (P = 0.003652) TRANSCRIPT LEVELS IN SLE PATIENTS WERE OBSERVED COMPARED WITH HEALTHY CONTROLS. NEVERTHELESS, THE DNMT3B MRNA EXPRESSION LEVELS WERE MARKEDLY LOWER COMPARED WITH DNMT1 AND DNMT3A, BOTH IN PBMCS FROM AFFECTED PATIENTS AND THOSE FROM CONTROL SUBJECTS. FURTHERMORE, THE DNMT1 TRANSCRIPT LEVELS WERE POSITIVELY CORRELATED WITH SLE DISEASE ACTIVITY INDEX (SLEDAI) (R (S) = 0.4087, P = 0.020224), WHILE THE DNMT3A TRANSCRIPT LEVELS WERE NEGATIVELY CORRELATED WITH PATIENTS AGE (R (S) = -0.3765, P = 0.03369). CONCLUSIONS: OUR ANALYSES CONFIRMED THE IMPORTANCE OF EPIGENETIC ALTERATIONS IN SLE ETIOLOGY. MOREOVER, OUR RESULTS SUGGEST THAT THE PRESENCE OF SOME CLINICAL MANIFESTATIONS, SUCH AS PHOTOTOSENSITIVITY AND ARTHRITIS, MIGHT BE ASSOCIATED WITH THE DYSREGULATION OF DNA METHYLTRANSFERASES' MRNA EXPRESSION LEVELS.	2017	
                                                                                                                                                                                                                   
8 4242  37 METHYLATION STATUS OF ALU AND LINE-1 INTERSPERSED REPETITIVE SEQUENCES IN BEHCET'S DISEASE PATIENTS. BEHCET'S DISEASE (BD) IS A MULTISYSTEM CHRONIC INFLAMMATORY DISEASE. THE PATHOLOGY IS BELIEVED TO INVOLVE BOTH GENETIC SUSCEPTIBILITY AND ENVIRONMENTAL FACTORS. HYPOMETHYLATION LEADING TO ACTIVATION OF INTERSPERSED REPETITIVE SEQUENCES (IRSS) SUCH AS LINE-1 AND ALU CONTRIBUTES TO THE PATHOLOGIES OF AUTOIMMUNE DISEASES AND CANCER. HEREIN, THE EPIGENETIC CHANGES OF IRSS IN BD WERE EVALUATED USING COMBINED BISULFITE RESTRICTION ANALYSIS-INTERSPERSED REPETITIVE SEQUENCES (COBRA-IRS). DNA FROM NEUTROPHILS AND PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) OF BD PATIENTS WITH OCULAR INVOLVEMENT THAT WERE IN ACTIVE OR INACTIVE STATES AND HEALTHY CONTROLS WERE USED TO ANALYZE LINE-1 AND ALU METHYLATION LEVELS. FOR ALU SEQUENCES, SIGNIFICANT DIFFERENCES WERE OBSERVED IN THE FREQUENCY OF (U)C(U)C ALLELES BETWEEN PBMCS OF PATIENTS AND CONTROLS (P = 0.03), AND BETWEEN INACTIVE PATIENTS AND CONTROLS (P = 0.03). FOR NEUTROPHILS, THE FREQUENCY OF (U)C(U)C WAS SIGNIFICANTLY HIGHER BETWEEN PATIENTS AND CONTROLS (P = 0.006) AND BETWEEN INACTIVE PATIENTS AND CONTROLS (P = 0.002). THE PARTIAL METHYLATION ((U)C(M)C + (M)C(U)C) FREQUENCIES OF ALU BETWEEN INACTIVE PATIENTS AND CONTROL SAMPLES ALSO DIFFERED (P = 0.02). NO STATISTICALLY SIGNIFICANT DIFFERENCES FOR LINE-1 WERE DETECTED. THUS, CHANGES IN THE METHYLATION LEVEL OF IRS ELEMENTS MIGHT CONTRIBUTE TO THE PATHOGENESIS OF BD. THE ROLE OF ALU TRANSCRIPTS IN BD SHOULD BE INVESTIGATED FURTHER.	2016	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
9 4221  38 METHYLATION AND SILENCING OF PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE O IN CHRONIC LYMPHOCYTIC LEUKEMIA. PURPOSE: PREVIOUS STUDIES IN OUR LABORATORY HAVE SHOWN THE PROGRESSIVE METHYLATION AND SUPPRESSION OF THE GENE ENCODING PROTEIN TYROSINE PHOSPHATASE, PTPRO, IN THE LIVERS OF RATS FED A METHYL-DEFICIENT DIET THAT INDUCES HEPATOCARCINOGENESIS. SUBSEQUENTLY, WE OBSERVED THE METHYLATION OF PTPRO IN PRIMARY HUMAN LUNG TUMORS AND ALSO SHOWED ITS POTENTIAL TUMOR SUPPRESSOR CHARACTERISTICS. THE PRESENT STUDY WAS UNDERTAKEN TO INVESTIGATE WHETHER THE TRUNCATED FORM OF PTPRO (PTPROT), SPECIFICALLY EXPRESSED IN NAIVE B LYMPHOCYTES, WAS ALSO METHYLATED AND SUPPRESSED IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), A DISEASE GENERALLY AFFECTING B LYMPHOCYTES. EXPERIMENTAL DESIGN AND RESULTS: INITIAL SCREENING SHOWED THAT 60% OF THE 52 CLL SAMPLES ANALYZED USING METHYLATION-SPECIFIC PCR ASSAY WERE METHYLATED COMPARED WITH B LYMPHOCYTES FROM NORMAL INDIVIDUALS, WHICH WERE NOT METHYLATED. THE EXPRESSION OF PTPROT, AS MEASURED BY SEMIQUANTITATIVE REVERSE TRANSCRIPTION-PCR, INVERSELY CORRELATED WITH METHYLATION IN THE FEW SAMPLES TESTED. ANALYSIS OF ADDITIONAL SAMPLES (N = 50) BY COMBINED BISULFITE RESTRICTION ANALYSIS SHOWED THAT THE PTPRO CPG ISLAND WAS METHYLATED IN 82% OF PATIENTS WITH CLL COMPARED WITH B LYMPHOCYTES FROM NORMAL INDIVIDUALS. FURTHERMORE, OVERALL EXPRESSION OF PTPRO WAS REDUCED IN CLL RELATIVE TO NORMAL LYMPHOCYTES. THE PTPRO GENE WAS ALSO SUPPRESSED BY METHYLATION IN THE CLL CELL LINE WAC3CD5, WHERE IT COULD BE REACTIVATED UPON TREATMENT WITH THE DNA HYPOMETHYLATING AGENT 5-AZAC. ECTOPIC EXPRESSION OF PTPROT IN A NONEXPRESSING CELL LINE INCREASED GROWTH INHIBITION WITH FLUDARABINE TREATMENT, A THERAPY COMMONLY USED FOR CLL. CONCLUSION: THIS STUDY REVEALS THE POTENTIAL ROLE OF PTPRO METHYLATION AND SILENCING IN CLL TUMORIGENESIS AND ALSO PROVIDES A NOVEL MOLECULAR TARGET IN THE EPIGENETIC THERAPY.	2007	
                                                                                                                                                                                                                                                                                                                                                                        
10 5205  32 PRENATAL STRESS CHANGES THE GLYCOPROTEIN GPM6A GENE EXPRESSION AND INDUCES EPIGENETIC CHANGES IN RAT OFFSPRING BRAIN. PRENATAL STRESS (PS) EXERTS STRONG IMPACT ON FETAL BRAIN DEVELOPMENT AND ON ADULT OFFSPRING BRAIN FUNCTIONS. PREVIOUS WORK DEMONSTRATED THAT CHRONIC STRESS ALTERS THE MRNA EXPRESSION OF GPM6A, A NEURONAL GLYCOPROTEIN INVOLVED IN FILOPODIUM EXTENSION. IN THIS WORK, WE ANALYZED THE EFFECT OF PS ON GPM6A EXPRESSION AND THE EPIGENETIC MECHANISMS INVOLVED. PREGNANT WISTAR RATS RECEIVED RESTRAINT STRESS DURING THE LAST WEEK OF GESTATION. MALE OFFSPRING WERE SACRIFICED ON POSTNATAL DAYS 28 AND 60. HIPPOCAMPUS AND PREFRONTAL CORTEX SAMPLES WERE ANALYZED FOR GENE EXPRESSION (QPCR FOR MRNAS AND MICRORNAS), METHYLATION STATUS (BISULFITE CONVERSION) AND PROTEIN LEVELS. HIPPOCAMPAL NEURONS IN CULTURE WERE USED TO ANALYZE MICRORNA OVEREXPRESSION EFFECTS. PRENATAL STRESS INDUCED CHANGES IN GPM6A LEVELS IN BOTH TISSUES AND AT BOTH AGES ANALYZED, INDICATING A PERSISTENT EFFECT. TWO CPG ISLANDS IN THE GPM6A GENE WERE IDENTIFIED. VARIATIONS IN THE METHYLATION PATTERN AT THREE SPECIFIC CPGS WERE FOUND IN HIPPOCAMPUS, BUT NOT IN PFC SAMPLES FROM PS OFFSPRING. MICRORNAS PREDICTED TO TARGET GPM6A WERE IDENTIFIED IN SILICO. QPCR MEASUREMENTS SHOWED THAT PS MODIFIED THE EXPRESSION OF SEVERAL MICRORNAS IN BOTH TISSUES, BEING MICRORNA-133B THE MOST SIGNIFICANTLY ALTERED. FURTHER STUDIES OVEREXPRESSING THIS MICRORNA IN NEURONAL CULTURES SHOWED A REDUCTION IN GMP6A MRNA AND PROTEIN LEVEL. MOREOVER FILOPODIUM DENSITY WAS ALSO REDUCED, SUGGESTING THAT GPM6A FUNCTION WAS AFFECTED. GESTATIONAL STRESS AFFECTED GPM6A GENE EXPRESSION IN OFFSPRING LIKELY THROUGH CHANGES IN METHYLATION STATUS AND IN POSTTRANSCRIPTIONAL REGULATION BY MICRORNAS. THUS, OUR FINDINGS PROPOSE GPM6A AS A NOVEL TARGET FOR EPIGENETIC REGULATION DURING PRENATAL STRESS.	2014	
                                                                                                                                                                                                                                                                                                                                                                                                                                                   
11 3866  37 JHDM1D AND HDAC1-3 MRNA EXPRESSION LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. BACKGROUND: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A CHRONIC RELAPSING AUTOIMMUNE DISEASE CHARACTERIZED BY PRODUCTION OF AUTOANTIBODIES AGAINST A SERIES OF NUCLEAR ANTIGENS AND BY CHRONIC INFLAMMATION. THE ETIOLOGY OF SLE IS THE RESULT OF INTERACTIONS BETWEEN GENETIC, EPIGENETIC, HORMONAL, AND ENVIRONMENTAL FACTORS. CHANGES IN HISTONE ACETYLATION AND METHYLATION CONTRIBUTE TO STRUCTURAL CHROMATIN MODIFICATIONS. OBJECTIVE: WE STUDIED THE HISTONE DEMETHYLASE JHDM1D AND HISTONE DEACETYLASES HDAC1, HDAC2, AND HDAC3 TRANSCRIPT LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) FROM PATIENTS DIAGNOSED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). FURTHERMORE, THE ASSOCIATION OF JHDM1D, HDAC1, HDAC2, AND HDAC3 TRANSCRIPT LEVELS WITH GENDER, AGE, AND MAJOR CLINICAL MANIFESTATIONS WERE ANALYZED. MATERIALS AND METHODS: REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION (RQ-PCR) ANALYSIS WAS USED TO DETERMINE JHDM1D, HDAC1, HDAC2, AND HDAC3 MRNA EXPRESSION LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) FROM 30 PATIENTS WITH SLE AND 36 HEALTHY CONTROLS. RESULTS: SIGNIFICANTLY LOWER HDAC2 TRANSCRIPT LEVELS (P = 0.006785) AND SIGNIFICANTLY HIGHER JHDM1D (P = 0.0000002) AND HDAC1 (P = 0.010581) TRANSCRIPT LEVELS IN SLE PATIENTS WERE OBSERVED COMPARED WITH HEALTHY CONTROLS. HIGHER JHDM1D MRNA EXPRESSION WAS DETECTED IN ACTIVE SLE PATIENTS WHEN COMPARED WITH INACTIVE PATIENTS (P = 0.005). FURTHERMORE, THE JHDM1D TRANSCRIPT LEVELS WERE POSITIVELY CORRELATED WITH DISEASE ACTIVITY (R(S) = 0.368, P = 0.045), WHILE HDAC2 MRNA EXPRESSION WAS POSITIVELY CORRELATED WITH DISEASE DURATION (R(S) = 0.502, P = 0.0047). CONCLUSION: OUR ANALYSES CONFIRMED THE IMPORTANCE OF EPIGENETIC ALTERATIONS (HISTONE DEMETHYLATION AND ACETYLATION) IN SLE ETIOLOGY. MOREOVER, OUR RESULTS SUGGEST THAT THE PRESENCE OF SOME CLINICAL MANIFESTATIONS, LIKE HEMATOLOGICAL DISEASE AND ANTI-RO ANTIBODY, MIGHT BE ASSOCIATED WITH THE DYSREGULATION OF HISTONE DEMETHYLASE AND DEACETYLASES MRNA EXPRESSION LEVELS.	2015	
                                                                                                                                                                              
12  977  42 CHRONIC ORAL EXPOSURE TO INORGANIC ARSENATE INTERFERES WITH METHYLATION STATUS OF P16INK4A AND RASSF1A AND INDUCES LUNG CANCER IN A/J MICE. ALTHOUGH INORGANIC ARSENATE (IAS(V)) OR ARSENITE (IAS(III)) IS CLEARLY A HUMAN CARCINOGEN, IT HAS BEEN DIFFICULT TO PRODUCE TUMORS IN RODENTS. IN THE PRESENT STUDY, WE ORALLY ADMINISTERED IAS(V) TO A/J MICE TO EXAMINE ARSENIC CARCINOGENICITY IN RODENT. A/J MICE (MALE, N = 120) ASSIGNED TO FOUR GROUPS WERE GIVEN DRINKING WATER CONTAINING 0, 1, 10, AND 100 PPM IAS(V) FOR 18 MONTHS. AT THE END OF EXPERIMENT, THE COMPLETE LUNGS WERE REMOVED AND USED FOR EXAMINING HISTOPATHOLOGY AND EXTRACTING RNA AND DNA. EPIGENETIC EFFECTS OF IAS(V) ON DNA METHYLATION PATTERNS OF P16INK4A AND RASSF1A GENES WERE DETERMINED BY METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION. CHANGES OF P16INK4A AND RASSF1A AT MRNA AND PROTEIN LEVELS WERE EXAMINED BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION AND IMMUNOHISTOCHEMISTRY. ARSENIC WAS ACCUMULATED DOSE DEPENDENTLY IN THE LUNG TISSUES OF IAS(V)-EXPOSED MICE. INCREASE IN LUNG TUMOR NUMBER AND LUNG TUMOR SIZE WAS OBSERVED IN IAS(V)-EXPOSED MICE COMPARED TO THE CONTROL. HISTOPATHOLOGICAL EXAMINATION SHOWED THAT THE RATE OF POORLY DIFFERENTIATED LUNG ADENOCARCINOMA WAS MUCH HIGHER IN IAS(V)-EXPOSED MICE THAN IN THE CONTROL. METHYLATION RATES APPEARED TO BE HIGHER IN A DOSE-RELATED TENDENCY IN LUNG TUMORS FROM IAS(V)-EXPOSED MICE COMPARED TO THE CONTROL. LOWER OR LOSS OF P16INK4A AND RASSF1A EXPRESSION WAS FOUND IN LUNG TUMORS FROM IAS(V)-EXPOSED MICE, COMPARED TO THAT IN NONTUMOR LUNG TISSUES FROM BOTH CONTROL AND IAS(V)-EXPOSED MICE, AND THIS REDUCED OR LOST EXPRESSION WAS IN ACCORDANCE WITH HYPERMETHYLATION OF THE GENES. IN CONCLUSION, IAS(V) EXPOSURE INCREASED LUNG TUMOR INCIDENCE AND MULTIPLICITY IN A/J MICE. EPIGENETIC CHANGES OF TUMOR SUPPRESSOR GENES SUCH AS P16INK4A AND RASSF1A ARE INVOLVED IN THE IAS(V)-INDUCED LUNG CARCINOGENESIS.	2006	
                                                                                                                                                                                                                                                                                                                                                                    
13 2327  40 EPIGENETIC REGULATION OF HUMAN CANCER/TESTIS ANTIGEN GENE, HAGE, IN CHRONIC MYELOID LEUKEMIA. BACKGROUND AND OBJECTIVES: CANCER TESTIS ANTIGENS (CTA) PROVIDE ATTRACTIVE TARGETS FOR CANCER-SPECIFIC IMMUNOTHERAPY. ALTHOUGH CTA GENES ARE EXPRESSED IN SOME NORMAL TISSUES, SUCH AS THE TESTIS, THIS IMMUNOLOGICALLY PROTECTED SITE LACKS MHC I EXPRESSION AND AS SUCH, DOES NOT PRESENT SELF ANTIGENS TO T CELLS. TO DATE, CTA GENES HAVE BEEN SHOWN TO BE EXPRESSED IN A RANGE OF SOLID TUMORS VIA DEMETHYLATION OF THEIR PROMOTER CPG ISLANDS, BUT RARELY IN CHRONIC MYELOID LEUKEMIA (CML) OR OTHER HEMATOLOGIC MALIGNANCIES. DESIGN AND METHODS: IN THIS STUDY, THE METHYLATION STATUS OF THE HAGE CTA GENE PROMOTER WAS ANALYZED BY QUANTITATIVE METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION (MSP) AND SEQUENCING IN FOUR PHILADELPHIA-POSITIVE CELL LINES (TCC-S, K562, KU812 AND KYO-1) AND IN CML SAMPLES TAKEN FROM PATIENTS IN CHRONIC PHASE (CP N=215) OR BLAST CRISIS (BC N=47). HAGE EXPRESSION WAS ASSESSED BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION. RESULTS: THE TCC-S CELL LINE SHOWED DEMETHYLATION OF HAGE THAT WAS ASSOCIATED WITH OVER-EXPRESSION OF THIS GENE. HAGE HYPOMETHYLATION WAS SIGNIFICANTLY MORE FREQUENT IN BC (46%) THAN IN CP (22%) (P=0.01) AND WAS CORRELATED WITH HIGH EXPRESSION LEVELS OF HAGE TRANSCRIPTS (P<0.0001). OF NOTE, IN CP-CML, EXTENSIVE HAGE HYPOMETHYLATION WAS ASSOCIATED WITH POORER PROGNOSIS IN TERMS OF CYTOGENETIC RESPONSE TO INTERFERON (P=0.01) OR IMATINIB (P=0.01), MOLECULAR RESPONSE TO IMATINIB (P=0.003) AND PROGRESSION-FREE SURVIVAL (P=0.05). INTERPRETATIONS AND CONCLUSION: THE METHYLATION STATUS OF THE HAGE PROMOTER DIRECTLY CORRELATES WITH ITS EXPRESSION IN BOTH CML CELL LINES AND PATIENTS AND IS ASSOCIATED WITH ADVANCED DISEASE AND POOR OUTCOME.	2007	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
14 1144  42 CONCOMITANT HETEROCHROMATINISATION AND DOWN-REGULATION OF GENE EXPRESSION UNVEILS EPIGENETIC SILENCING OF RELB IN AN AGGRESSIVE SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA IN MALES. BACKGROUND: THE SENSITIVITY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS TO CURRENT TREATMENTS, BOTH IN VITRO AND IN VIVO, RELIES ON THEIR ABILITY TO ACTIVATE APOPTOTIC DEATH. CLL CELLS RESISTANT TO DNA DAMAGE-INDUCED APOPTOSIS DISPLAY DEREGULATION OF A SPECIFIC SET OF GENES. METHODS: MICROARRAY HYBRIDIZATION (HUMAN GENECHIP, AFFYMETRIX), IMMUNOFLUORESCENT IN SITU LABELING COUPLED WITH VIDEO-MICROSCOPY RECORDING/ANALYSES, CHROMATIN-IMMUNOPRECIPITATION (CHIP), POLYMERASE CHAIN REACTIONS (PCR), REAL-TIME QUANTITATIVE PCR (RT-QPCR) AND BISULFITE GENOME SEQUENCING WERE THE MAIN METHODS APPLIED. STATISTICAL ANALYSES WERE PERFORMED BY APPLYING GCRMA AND SAM ANALYSIS (MICROARRAY DATA) AND STUDENT'S T-TEST OR MANN & WHITNEY'S U-TEST. RESULTS: HEREIN WE SHOW THAT, REMARKABLY, IN A RESISTANT MALE CLL CELLS THE VAST MAJORITY OF GENES WERE DOWN-REGULATED COMPARED WITH SENSITIVE CELLS, WHEREAS THIS WAS NOT THE CASE IN CELLS DERIVED FROM FEMALES. THIS GENE DOWN-REGULATION WAS FOUND TO BE ASSOCIATED WITH AN OVERALL GAIN OF HETEROCHROMATIN AS EVIDENCED BY IMMUNOFLUORESCENT LABELING OF HETEROCHROMATIN PROTEIN 1ALPHA (HP-1), TRIMETHYLATED HISTONE 3 LYSINE 9 (3METH3K9), AND 5-METHYLCYTIDINE (5METC). NOTABLY, 17 GENES WERE FOUND TO BE COMMONLY DEREGULATED IN RESISTANT MALE AND FEMALE CELL SAMPLES. AMONG THESE, RELB WAS IDENTIFIED AS A DISCRIMINATORY CANDIDATE GENE REPRESSED IN THE MALE AND UPREGULATED IN THE FEMALE RESISTANT CELLS. CONCLUSION: THE MOLECULAR DEFECTS IN THE SILENCING OF RELB INVOLVE AN INCREASE IN H3K9- BUT NOT CPG-ISLAND METHYLATION IN THE PROMOTER REGIONS. INCREASE IN ACETYL-H3 IN RESISTANT FEMALE BUT NOT MALE CLL SAMPLES AS WELL AS A DECREASE OF TOTAL CELLULAR LEVEL OF RELB AFTER AN INHIBITION OF HISTONE DEACETYLASE (HDAC) BY TRICHOSTATIN A (TSA), FURTHER EMPHASIZE THE ROLE OF EPIGENETIC MODIFICATIONS WHICH COULD DISCRIMINATE TWO CLL SUBSETS. TOGETHER, THESE RESULTS HIGHLIGHTED THE EPIGENETIC RELB SILENCING AS A NEW MARKER OF THE PROGRESSIVE DISEASE IN MALES.	2010	
                                                                                                                        
15 2921  37 GENE-SPECIFIC DIFFERENTIAL DNA METHYLATION AND CHRONIC ARSENIC EXPOSURE IN AN EPIGENOME-WIDE ASSOCIATION STUDY OF ADULTS IN BANGLADESH. BACKGROUND: INORGANIC ARSENIC IS ONE OF THE MOST COMMON NATURALLY OCCURRING CONTAMINANTS FOUND IN THE ENVIRONMENT. ARSENIC IS ASSOCIATED WITH A NUMBER OF HEALTH OUTCOMES, WITH EPIGENETIC MODIFICATION SUGGESTED AS A POTENTIAL MECHANISM OF TOXICITY. OBJECTIVE: AMONG A SAMPLE OF 400 ADULT PARTICIPANTS, WE EVALUATED THE ASSOCIATION BETWEEN ARSENIC EXPOSURE, AS MEASURED BY BLOOD AND URINARY TOTAL ARSENIC CONCENTRATIONS, AND EPIGENOME-WIDE WHITE BLOOD CELL DNA METHYLATION. METHODS: WE USED LINEAR REGRESSION MODELS TO EXAMINE THE ASSOCIATIONS BETWEEN ARSENIC EXPOSURE AND METHYLATION AT EACH CPG SITE, ADJUSTED FOR SEX, AGE, AND BATCH. DIFFERENTIALLY METHYLATED LOCI WERE SUBSEQUENTLY EXAMINED IN RELATION TO CORRESPONDING GENE EXPRESSION FOR FUNCTIONAL EVIDENCE OF GENE REGULATION. RESULTS: IN ADJUSTED ANALYSES, WE OBSERVED FOUR DIFFERENTIALLY METHYLATED CPG SITES WITH URINARY TOTAL ARSENIC CONCENTRATION AND THREE DIFFERENTIALLY METHYLATED CPG SITES WITH BLOOD ARSENIC CONCENTRATION, BASED ON THE BONFERRONI-CORRECTED SIGNIFICANCE THRESHOLD OF P < 1 X 10(-7). METHYLATION OF PLA2G2C (PROBE CG04605617) WAS THE MOST SIGNIFICANTLY ASSOCIATED LOCUS IN RELATION TO BOTH URINARY (P = 3.40 X 10(-11)) AND BLOOD ARSENIC CONCENTRATIONS (P = 1.48 X 10(-11)). THREE ADDITIONAL NOVEL METHYLATION LOCI-SQSTM1 (CG01225779), SLC4A4 (CG06121226), AND IGH (CG13651690)--WERE ALSO SIGNIFICANTLY ASSOCIATED WITH ARSENIC EXPOSURE. FURTHER, THERE WAS EVIDENCE OF METHYLATION-RELATED GENE REGULATION BASED ON GENE EXPRESSION FOR A SUBSET OF DIFFERENTIALLY METHYLATED LOCI. CONCLUSIONS: WE OBSERVED SIGNIFICANT ASSOCIATIONS BETWEEN ARSENIC EXPOSURE AND GENE-SPECIFIC DIFFERENTIAL WHITE BLOOD CELL DNA METHYLATION, SUGGESTING THAT EPIGENETIC MODIFICATIONS MAY BE AN IMPORTANT PATHWAY UNDERLYING ARSENIC TOXICITY. THE SPECIFIC DIFFERENTIALLY METHYLATED LOCI IDENTIFIED MAY INFORM POTENTIAL PATHWAYS FOR FUTURE INTERVENTIONS.	2015	
                                                                                                                                                                                                                                                        
16 1729  39 DYSREGULATION OF MIR-155 EXPRESSION IN PROFESSIONAL MIXED MARTIAL ARTS (MMA) FIGHTERS. PSYCHOLOGICAL AND PHYSICAL STRESS CAN INDUCE DYSREGULATION OF GENE EXPRESSION VIA CHANGES IN DNA METHYLATION AND MICRORNA (MIRNA) EXPRESSION. SUCH EPIGENETIC MODIFICATIONS ARE YET TO BE INVESTIGATED IN PROFESSIONAL MIXED MARTIAL ARTS (MMA) FIGHTERS SUBJECT TO HIGHLY STRESSFUL TRAINING INVOLVING REPETITIVE HEAD IMPACTS. THIS STUDY EXAMINED DIFFERENCES IN DNA METHYLATION AND MIRNA EXPRESSION IN ELITE MMA FIGHTERS COMPARED TO ACTIVE CONTROLS. GLOBAL METHYLATION DIFFERENCES BETWEEN GROUPS WERE ASSESSED VIA A LINE-1 ASSAY. AT THE SAME TIME, PCR ARRAYS WERE USED TO ESTIMATE DIFFERENTIAL EXPRESSION IN SAMPLES OF 21 FIGHTERS AND 15 CONTROLS FOR 192 DIFFERENT MIRNAS ASSOCIATED WITH INFLAMMATORY DISEASES. AN INDEPENDENT-SAMPLES T-TEST FOUND NO SIGNIFICANT DIFFERENCE IN LINE-1 METHYLATION BETWEEN GROUPS. HOWEVER, AN INDEPENDENT-SAMPLES MANN-WHITNEY U TEST REVEALED A SIGNIFICANT UPREGULATION IN THE EXPRESSION OF MIR-155 IN MMA FIGHTER PLASMA. SINCE MIR-155 HAS BEEN RECOGNIZED AS AN IMPORTANT REGULATOR OF NEUROINFLAMMATION, THIS DYSREGULATION SUGGESTS A POSSIBLE EPIGENETIC MECHANISM RESPONSIBLE FOR CHRONIC INFLAMMATION ASSOCIATED WITH PROFESSIONAL-LEVEL MMA TRAINING. CONSISTENT WITH OTHER PUBLISHED WORKS, THIS STUDY HIGHLIGHTS THE POTENTIAL OF MIR-155 NOT ONLY AS A BIOMARKER FOR MONITORING LONG-TERM HEALTH RISKS LINKED TO HEAD TRAUMA BUT ALSO AS A TARGET TO REMEDIATE THE IMPACT OF CHRONIC NEUROINFLAMMATION.	2023	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
17  505  33 ASSOCIATION OF DNA METHYLTRANSFERASE 3B PROMOTOR POLYMORPHISM WITH CHILDHOOD CHRONIC IMMUNE THROMBOCYTOPENIA. BACKGROUND: DNA METHYLATION IS AN EPIGENETIC PROCESS THAT REFERS TO CHROMATIN-BASED MECHANISMS IN THE REGULATION OF GENE EXPRESSION WITHOUT DNA ALTERNATION. IT IS MEDIATED BY DNA METHYLTRANSFERASES (DNMTS). THE DNA METHYLTRANSFERASE 3B (DNMT3B) GENE CONTAINS A C-TO-T SINGLE NUCLEOTIDE POLYMORPHISM (SNP; RS2424913) IN THE PROMOTOR REGION, 149 BASE PAIRS FROM THE TRANSCRIPTION START SITE, WHICH IS REPORTED TO SIGNIFICANTLY INCREASE THE PROMOTOR ACTIVITY. OBJECTIVE: TO INVESTIGATE THE PREVALANCE OF RS2424913 SINGLE NUCLEOTIDE POLYMORPHISM LOCATED IN THE DNMT3B GENE PROMOTOR. METHODS: IN THE PRESENT STUDY, WE INVESTIGATED THE PREVALENCE OF RS2424913 SINGLE NUCLEOTIDE POLYMORPHISM LOCATED IN DNMT3B GENE PROMOTOR BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM (PCR-RFLP) IN EGYPTIAN PEDIATRIC CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS AND CONTROLS. RESULTS: THE HOMOZYGOUS GENOTYPE (TT) WAS SIGNIFICANTLY HIGHER IN OUR PATIENT AND CONFERRED ALMOST 3-FOLD INCREASED RISK OF CHRONIC ITP WHEN COMPARED TO CONTROLS. CONCLUSION: THE PRESENT STUDY SHOWS THAT DNMT3B RS2424913 PROMOTOR POLYMORPHISM REPRESENTS A GENETIC RISK FACTOR THAT MAY PLAY AN IMPORTANT ROLE IN UNDERSTANDING THE PATHOGENESIS OF CHRONIC ITP.	2016	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
18 5270  35 PROMOTER DNA METHYLATION FREQUENCY AND CLINICOPATHOLOGICAL ROLE OF MIR-129-2 GENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. OBJECTIVES: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IS CHARACTERIZED BY THE ACCUMULATION OF APPARENTLY MATURE B-TYPE LYMPHOCYTES IN THE LYMPHOHEMATOPOIETIC ORGANS. METHYLATION IN PROMOTERS OF TUMOR SUPPRESSOR GENES IS ONE OF THE MECHANISMS THAT CAUSES BLOOD MALIGNANCY. IN THIS STUDY, WE EVALUATED THE PROMOTER DNA METHYLATION STATUS OF MIR-129-2 TUMOR SUPPRESSOR GENE AND ITS ASSOCIATION WITH CLINICAL AND LABORATORY PARAMETERS OF PATIENTS WITH CLL. METHODS: WE STUDIED THE PROMOTER DNA METHYLATION FREQUENCY OF THE MIR-129-2 GENE IN 50 PATIENTS WITH CLL AND 50 HEALTHY CONTROLS USING METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION METHODS. STATISTICAL ANALYSIS WAS PERFORMED USING SPSS-18 SOFTWARE, AND A P-VALUE < 0.050 WAS CONSIDERED STATISTICALLY SIGNIFICANT. RESULTS: THE FREQUENCY OF PROMOTER DNA METHYLATION OF THE MIR-129-2 GENE WAS SIGNIFICANTLY HIGHER IN THE CLL GROUP COMPARED WITH CONTROL GROUP (38.0% VS. 0.0%, P < 0.001; CHI(2) = 23.457). THE PROMOTER DNA METHYLATION FREQUENCY OF MIR-129-2 GENE WAS NOT SIGNIFICANTLY DIFFERENT BETWEEN THE TWO SEXES (P = 0.236). A SIGNIFICANT BUT WEAK CORRELATION WAS SEEN BETWEEN THE METHYLATED STATE OF THE MIR-129-2 GENE AND ORGANOMEGALY (P = 0.019, R = 0.330) AS WELL AS HEMOGLOBIN LEVELS (P = 0.020, R = -0.233). HOWEVER, BINARY LOGISTIC REGRESSION ANALYSIS INDICATED ORGANOMEGALY AS THE ONLY CLINICAL BIOMARKER WITH A STATISTICALLY SIGNIFICANT ASSOCIATION WITH THE HYPERMETHYLATED MIR-129-2 GENE STATE (P = 0.046). CONCLUSIONS: THE HIGH FREQUENCY OF PROMOTER DNA METHYLATION OF THE MIR-129-2 GENE IN THE CLL GROUP COMPARED TO THE CONTROL GROUP, AS WELL AS ITS SIGNIFICANT ASSOCIATION WITH ORGANOMEGALY, SUGGESTS THE IMPORTANCE OF THIS EPIGENETIC BIOMARKER IN THE PATHOGENESIS AND PROGNOSIS OF CLL DISEASE.	2020	
                                                                                                                                                                                                                                                                                                                                                                                                                   
19 1011  30 CIGARETTE SMOKE CONDENSATE INDUCES DIFFERENTIAL EXPRESSION AND PROMOTER METHYLATION PROFILES OF CRITICAL GENES INVOLVED IN LUNG CANCER IN NL-20 LUNG CELLS IN VITRO: SHORT-TERM AND CHRONIC EXPOSURE. ESTABLISHING EARLY DIAGNOSTIC MARKERS OF HARM IS CRITICAL FOR EFFECTIVE PREVENTION PROGRAMS AND REGULATION OF TOBACCO PRODUCTS. THIS STUDY EXAMINED EFFECTS OF CIGARETTE SMOKE CONDENSATE (CSC) ON EXPRESSION AND PROMOTER METHYLATION PROFILE OF CRITICAL GENES (DAPK, ECAD, MGMT, AND RASSF1A) INVOLVED IN LUNG CANCER DEVELOPMENT IN DIFFERENT HUMAN LUNG CELL LINES. NL-20 CELLS WERE TREATED WITH 0.1-100 MUG/ML OF CSC FOR 24 TO 72 HRS FOR SHORT-TERM EXPOSURES. DAPK EXPRESSION OR METHYLATION STATUS WAS NOT SIGNIFICANTLY AFFECTED. HOWEVER, CSC TREATMENT RESULTED IN CHANGES IN EXPRESSION AND PROMOTER METHYLATION PROFILE OF ECAD, MGMT, AND RASSF1A. FOR CHRONIC STUDIES, CELLS WERE EXPOSED TO 1 OR 10 MUG/ML CSC UP TO 28 DAYS. CELLS SHOWED MORPHOLOGICAL CHANGES ASSOCIATED WITH TRANSFORMATION AND CHANGES IN INVASION CAPACITIES AND GLOBAL METHYLATION STATUS. THIS STUDY PROVIDES CRITICAL DATA SUGGESTING THAT EPIGENETIC CHANGES COULD SERVE AS AN EARLY BIOMARKER OF HARM DUE TO EXPOSURE TO CIGARETTE SMOKE.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
20  494  33 ASSESSMENT OF PROMOTER METHYLATION IDENTIFIES PTCH AS A PUTATIVE TUMOR-SUPPRESSOR GENE IN HUMAN CLL. BACKGROUND: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IS CHARACTERIZED BY A CLONAL ACCUMULATION OF NEOPLASTIC LYMPHOCYTES, INDICATING DISRUPTION OF APOPTOSIS. PATIENTS AND METHODS: DIFFERENTIAL METHYLATION HYBRIDIZATION ANALYSIS WAS PERFORMED TO IDENTIFY NOVEL TARGET GENES SILENCED BY CPG ISLAND METHYLATION IN PATIENTS WITH CLL. RESULTS: PATCHED (PTCH), A TUMOR-SUPPRESSOR GENE, WAS FOUND TO BE FREQUENTLY METHYLATED IN CLL SAMPLES COMPARED TO SAMPLES DERIVED FROM HEALTHY INDIVIDUALS. DE NOVO METHYLATION OF A CPG ISLAND REGION LOCATED UPSTREAM OF PTCH EXON 1 WAS CONFIRMED BY PYROSEQUENCING IN 17/37 (46%) OF PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH CLL, BUT IN NONE ISOLATED FROM SEVEN HEALTHY INDIVIDUALS. NO ASSOCIATION WAS FOUND BETWEEN PTCH HYPERMETHYLATION AND CURRENTLY USED PROGNOSTIC CLL FACTORS. CONCLUSION: OUR INVESTIGATION SUGGESTS THAT EPIGENETIC SILENCING OF PTCH IS A MECHANISM CONTRIBUTING TO CLL TUMORIGENESIS.	2016